药物治疗慢性腰部疼痛的药物药剂的比较有效性和安全性:系统性审查和贝叶斯双变网络元分析协议
Oluwasegun Aremu1,2, Oluwatomisin Ogunlade2, Terver Mata3
1Department of Surgery, University of Ibadan, Ibadan, Nigeria segunaremu2k3@yahoo.com.
BMJ open
|September 29, 2025
概括
这项研究根据有效性和安全性对慢性腰部疼痛的止痛药进行了排名. 它使用网络元分析来比较药物,帮助临床医生为患者选择最佳治疗方法.
科学领域:
- 疼痛管理 疼痛管理
- 药物治疗 药物治疗
- 基于证据的医学基于证据的医学.
背景情况:
- 慢性腰部疼痛是导致残疾的主要原因,终身患病率很高.
- 药物治疗是慢性腰部疼痛的关键治疗方法,得到临床指南的支持.
- 目前的证据缺乏统一的止痛药的有效性和安全性等级.
研究的目的:
- 根据疗效和安全性,识别和排名慢性腰部疼痛的药理疗剂.
- 进行多变量双变量网络元分析,比较疼痛缓解和不良事件.
主要方法:
- 在四个数据库 (Medline/Pubmed,Cochrane,CINAHL) 系统搜索随机对照试验,直到2024年7月31日.
- 提取关于疼痛强度得分和因不良事件而导致患者退出的数据.
- 双变贝叶斯网络元分析以结合结果和对药物治疗进行排名;偏差风险和使用GRADE的证据分级.
主要成果:
- 该研究将根据疼痛缓解和安全性概况的综合分析对药物治疗剂进行排名.
- 将提供药物疗效和耐受性的全面比较.
结论:
- 这个网络的元分析将提供对慢性腰部疼痛最有效和最安全的药物治疗的排名列表.
- 结果将指导临床决策在疼痛管理,优化患者的结果.
相关概念视频
Bioequivalence of Drugs: Drugs with Multiple Indications
150
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
150
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
407
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
407


